Fatty Liver, NASH, Cirrhosis - Can They Be Stopped??? Dr. Robert Foster, CEO Hepion Pharmaceuticals

Did you know that 1 in 4 Americans suffer from fatty liver disease? And that can lead to a more serious condition called Nash, which can ultimately cause cirrhosis of the liver. Hepion Pharmaceuticals is currently in clinical trials to successfully treat Nash. Learn more about how to take care of your liver on today's episode of BioTech Nation with Dr. Robert Foster, CEO of Hepion Pharmaceuticals.